EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel tRNA Half mt‐5’‐tiRNA‐Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation

Xinliang Gu iD, Danping Zhu, Xinwei Liu, Shangshang Hu iD, Xincheng Yang iD, Junjie Nie, Tao Xu, Yuqin Pan, Mu Xu iD, Huiling Sun, Shukui Wang iD

Advanced Science · 2026-10 · 13 (57)

DOI: 10.1002/advs.77042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.08.2026. Verfasst von Xinliang Gu und 10 weiteren Autor:innen. Beteiligte Einrichtung: General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, RNA, Transfer, RNA, Small Untranslated. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Province Medical Key Discipline Construction unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transfer RNA‐derived small RNAs (tsRNAs) are a novel class of small non‐coding RNAs abundant in the bloodstream of cancer patients and involved in various physiological and pathological processes. However, the regulatory mechanisms and clinical significance of tsRNAs in colorectal cancer (CRC) remain unclear. In this study, PANDORA‐seq was used as an exploratory screen of CRC tissues, paired adjacent tissues, and CRC plasma samples, followed by validation in larger independent cohorts. Quantitative real‐time PCR quantified mt‐5’‐tiRNA‐Tyr levels in tissues, plasma, and cells. Functional assays assessed the role of mt‐5’‐tiRNA‐Tyr in CRC. Mechanistic studies utilized RNA pull‐down, mass spectrometry, RNA immunoprecipitation, western blotting, and Co‐immunoprecipitation. Results revealed that mt‐5’‐tiRNA‐Tyr was significantly upregulated in CRC plasma and tissues. In vitro and in vivo studies demonstrated its oncogenic potential. Mechanistic assays showed that mt‐5’‐tiRNA‐Tyr was enriched with HARS2 in RNA pull‐down/RIP assays and associated with reduced HARS2‐mt‐tRNA‐His association, increased HARS2 K91 succinylation, impaired mitochondrial protein translation, and mitochondrial damage. Moreover, succinate accumulation creates a positive feedback loop that enhances CRC proliferation. This study identifies a novel oncogenic tsRNA and uncovers a mechanism by which mt‐5’‐tiRNA‐Tyr promotes CRC proliferation through HARS2 succinylation, supporting further evaluation of plasma mt‐5’‐tiRNA‐Tyr as a candidate circulating biomarker for CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsRNA, TransferRNA, Small UntranslatedHumansCell ProliferationAnimalsMiceCell Line, TumorMaleFemaleGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

HARS2colorectal cancermt‐5’‐tiRNA‐TyrsuccinylationtRNA‐derived small RNAs

Substanzen

RNA, TransferRNA, Small Untranslated

Autor:innen und Institutionen

  • General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
  • Department of Laboratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Jiangsu Collaborative Innovation Center on Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Nanjing Medical Key Laboratory of Laboratory Diagnostics, Nanjing, Jiangsu, China.

ORCID-Profile: Xinliang Gu, Shangshang Hu, Xincheng Yang, Mu Xu, Shukui Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Jiangsu Province Medical Key Discipline Construction unit
  • Nanjing Medical and Health Scientific Research Project
  • Jiangsu Provincial Medical Key Discipline Cultivation Unit

Zitieren

APA

Gu, X., Zhu, D., Liu, X., Hu, S., Yang, X., Nie, J., Xu, T., Pan, Y., Xu, M., Sun, H., & Wang, S. (2026). A Novel tRNA Half mt‐5’‐tiRNA‐Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. Advanced Science, 13(57). https://doi.org/10.1002/advs.77042

Vancouver

Gu X, Zhu D, Liu X, Hu S, Yang X, Nie J, et al. A Novel tRNA Half mt‐5’‐tiRNA‐Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. Advanced Science. 2026;13(57). doi:10.1002/advs.77042

BibTeX
@article{Gu2026,
  author = {Gu, Xinliang and Zhu, Danping and Liu, Xinwei and Hu, Shangshang and Yang, Xincheng and Nie, Junjie and Xu, Tao and Pan, Yuqin and Xu, Mu and Sun, Huiling and Wang, Shukui},
  title = {A Novel tRNA Half mt‐5’‐tiRNA‐Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {57},
  doi = {10.1002/advs.77042}
}
Kostenlos starten →